NOV Inc. designs, constructs, manufactures, and sells systems, components, and products for oil and gas drilling and production, and industrial and renewable energy sectors in the United States and internationally. It operates through two segments, Energy Equipment, and Energy Products and Services. The company provides solids control and waste management equipment and services, managed pressure drilling, drilling fluids, premium drillpipe, wired pipe, drilling optimization services, tubular inspection and coating services, instrumentation, downhole tools, and drill bits. It also offers equipment and technologies for hydraulic fracture stimulation, including downhole multistage fracturing tools, pressure pumping trucks, blenders, sanders, hydration and injection units, flowline, and manifolds; coiled tubing units, and wireline units and tools; connections and liner hangers; onshore production consists of composite pipe, surface transfer and progressive cavity pumps, and artificial lift systems; and offshore production, such as floating production systems and subsea production technologies, as well as manufactures industrial pumps and mixers. In addition, the company provides substructures, derricks, and masts; cranes; jacking systems; pipe lifting, racking, rotating, and assembly systems; mud pumps; pressure control equipment; drives and generators; rig instrumentation and control systems; mooring, anchor, and deck handling machinery; equipment components for offshore wind construction vessels; and pipelay and construction systems. Further, the company offers spare parts, repair, and rentals as well as comprehensive remote equipment monitoring, technical support, field service, and customer training. The company was formerly known as National Oilwell Varco, Inc. and changed its name to NOV Inc. in January 2021. NOV Inc. was founded in 1862 and is based in Houston, Texas.

NOV Inc.

Novamarine S.P.A. ( ($IT:NOVA) ) has shared an update. Novamarine S.p.A., the Italian boatmaker listed on Euronext Growth Milan, has called an extr...

Novamarine Calls Extraordinary Meeting to Update Statutes and Authorize Capital Increase

WSW, NY, July 23rd, 2026, FinanceWire Nuvectis Pharma (NASDAQ:NVCT) announced this morning that ciprocopan (NXP100) has been approved by China’s Na...

Nuvectis’ NXP100 Just Achieved the First Marketing Approval Ever for a Once-Daily Oral Factor B Inhibitor

DZ BANK AG analyst Elmar Kraus maintained a Hold rating on Novartis AG yesterday. The company’s shares closed yesterday at CHF125.34. Kraus covers ...

Novartis AG (NOVN) Gets a Hold from DZ BANK AG

In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Novartis AG, with a price target of CHF135.00. According to ...

Novartis AG (NOVN) Gets a Buy from J.P. Morgan

Novo Nordisk ( ($NVO) ) has shared an announcement. On 6 May 2026, Novo Nordisk A/S launched a share repurchase programme under EU Safe Harbour rul...

Novo Nordisk Ramps Up DKK 15 Billion Share Buyback Programme

Bernstein analyst Justin Smith maintained a Hold rating on Novartis AG today and set a price target of CHF125.00. According to TipRanks, Smith is a...

Novartis AG (NOVN) Receives a Hold from Bernstein

Jefferies analyst Michael Leuchten maintained a Hold rating on Novartis AG today and set a price target of CHF110.00. According to TipRanks, Leucht...

Jefferies Keeps Their Hold Rating on Novartis AG (NOVN)

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on Novo Nordisk, with a price target of DKK290.00. Accor...

Novo Nordisk (0QIU) Receives a Hold from Deutsche Bank

Bank of America Securities analyst Saurabh Pant maintained a Buy rating on NOV today and set a price target of $23.00. According to TipRanks, Pant ...

Bank of America Securities Reaffirms Their Buy Rating on NOV (NOV)

Jefferies analyst reiterated a Buy rating on Enovis today and set a price target of $40.00. Enovis has an analyst consensus of Strong Buy, with a p...

Enovis (ENOV) Receives a Buy from Jefferies

In a report released yesterday, Matthew Weston from UBS maintained a Hold rating on Novartis AG, with a price target of CHF116.00. According to Tip...

UBS Reaffirms Their Hold Rating on Novartis AG (NOVN)

In a report released today, Matthew Weston from UBS maintained a Hold rating on Novo Nordisk, with a price target of DKK332.00. According to TipRan...

Novo Nordisk (0QIU) Receives a Hold from UBS

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on Novartis AG, with a price target of CHF140.00. Accordi...

Novartis AG (NOVN) Receives a Buy from Deutsche Bank

RBC Capital analyst Keith Mackey maintained a Hold rating on NOV yesterday and set a price target of $22.00. According to TipRanks, Mackey is a 5-s...

RBC Capital Keeps Their Hold Rating on NOV (NOV)

Novacyt ( ($FR:ALNOV) ) has shared an announcement. Novacyt reported activity under its French-governed liquidity agreement with Invest Securities ...

Novacyt Updates Market on Liquidity Agreement and Voting Rights

Artificial intelligence (AI) is becoming more integrated into medical labs, with major tech firms now building tools to speed up research. On Tuesd...

Anthropic Launches Claude Science AI Tool to Upend Lab and Pharma Research

The latest update is out from Novamarine S.P.A. ( ($IT:NOVA) ). Novamarine has signed a contract with an Italian private client for the first unit ...

Novamarine Sells First Unit of Flagship BS 260 Maxi‑RIB

An update from Novacyt ( ($FR:ALNOV) ) is now available. Novacyt shareholders approved all ordinary resolutions and several extraordinary resolutio...

Novacyt wins shareholder backing for growth-focused AGM resolutions

In a report released today, Michael Leuchten from Jefferies maintained a Hold rating on Novo Nordisk, with a price target of DKK285.00. According t...

Jefferies Sticks to Their Hold Rating for Novo Nordisk (0QIU)

In a report released today, James Gordon CFA from Barclays maintained a Hold rating on Novartis AG, with a price target of CHF120.00. Gordon CFA co...

Barclays Reaffirms Their Hold Rating on Novartis AG (NOVN)

Novo Nordisk ( ($NVO) ) has shared an update. On 6 May 2026, Novo Nordisk launched a share repurchase programme under EU Safe Harbour rules as part...

Novo Nordisk Accelerates Share Buybacks Under DKK 15 Billion Programme

Novamarine S.P.A. ( ($IT:NOVA) ) just unveiled an update. Novamarine S.p.A., an Italian maker of high‑performance pleasure boats and professional v...

Novamarine Launches “Black Force” Professional Tender Line to Drive Global Expansion

Novatti Group ( ($AU:NOV) ) has shared an announcement. Novatti Group has sold 1.5 million shares in AUDC Pty Ltd at $0.80 per share, realising $1....

	A	B	C	D
1	Symbol	Price	Change	Volume
2	NOV	$20.76	+3.13%	4.16M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	NOV	$20.76	+3.1%	4.16M
3
4
5
6

NOV

NOV

Get NOV Inc. Data in Excel

Get NOV Inc. Data in Excel